ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

HCID 86600751、化合物 → HCID 11215979、化合物

HRID 2252457
ノート
印刷プレビュー

反応式

HRID 2252457 の反応式
C([O:8][C@@H:9]1[C@@H:16]([O:17]CC2C=CC=CC=2)[C@H:15]([O:25]CC2C=CC=CC=2)[C@@H:14]([CH2:33][O:34][C:35]2[CH:36]=[C:37]([C:41]3[CH:46]=[CH:45][C:44]([C@@H:47]4[C@@H:50]([CH2:51][CH2:52][C@@H:53]([C:55]5[CH:60]=[CH:59][C:58]([F:61])=[CH:57][CH:56]=5)[OH:54])[C:49](=[O:62])[N:48]4[C:63]4[CH:68]=[CH:67][C:66]([F:69])=[CH:65][CH:64]=4)=[CH:43][CH:42]=3)[CH:38]=[CH:39][CH:40]=2)[O:13][C@@H:10]1[O:11][CH3:12])C1C=CC=CC=1>C(O)C.[Pd]>[F:69][C:66]1[CH:67]=[CH:68][C:63]([N:48]2[C:49](=[O:62])[C@H:50]([CH2:51][CH2:52][C@@H:53]([C:55]3[CH:56]=[CH:57][C:58]([F:61])=[CH:59][CH:60]=3)[OH:54])[C@H:47]2[C:44]2[CH:43]=[CH:42][C:41]([C:37]3[CH:38]=[CH:39][CH:40]=[C:35]([O:34][CH2:33][C@H:14]4[O:13][C@H:10]([O:11][CH3:12])[C@H:9]([OH:8])[C@@H:16]([OH:17])[C@@H:15]4[OH:25])[CH:36]=3)=[CH:46][CH:45]=2)=[CH:64][CH:65]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

4

反応物 1

HCID 86600751HCID 86600751、化合物

生成物 1

HCID 11215979HCID 11215979、化合物収率 36%

試薬・触媒・溶媒 2

HCID 23938Palladium触媒HCID 702Ethanol溶媒

実験手順

Methyl 2,3,4-tri-O-benzyl-6-O-(4′-{(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl}biphenyl-3-yl)-α-D-glucopyranoside (70 mg, 0.08 mmol) was dissolved in absolute ethanol (3 mL). 10% Pd/C (wet, 14% w/w) was added and the vessel sealed. The solution was degassed by evacuation and flushing with hydrogen gas at balloon pressure. The reaction was monitored by TLC (1:1 hexane-ethyl acetate). Upon completion, the catalyst was filtered by passing through a plug of Celite® and washing with additional ethanol. The filtrate was concentrated in vacuo and purified by preparative HPLC (Polaris C18-A 10 μ 250×21.2 mm column, 30% to 95% acetonitrile-0.1% trifluoroacetic acid in water) affording methyl 6-O-(4′-{(2S,3R)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-oxoazetidin-2-yl}biphenyl-3-yl)-α-D-glucopyranoside (18.1 mg, 36% yield); 1H NMR (300 MHz, CDCl3/1% CD3OD) δ 7.58 (d, J=8.4 Hz, 2H), 7.38-7.23 (m, 7H), 7.17-7.14 (m, 2H), 7.04-6.92 (m, 5H), 4.80 (d, J=3.9 Hz, 1H), 4.70 (d, J=2.4 Hz, 1H), 4.67 (t, J=5.7 Hz, 1H), 4.37-4.33 (m, 1H), 4.26-4.21 (m, 1H), 3.92-3.87 (m, 1H), 3.74-3.45 (m, 3H), 3.42 (s, 3H), 3.18-3.10 (m, 1H), 2.01-1.88 (m, 4H) ppm; MS [M−OH]+ 644.0.

後処理

  1. customthe vessel sealed
  2. customThe solution was degassed by evacuation
  3. customflushing with hydrogen gas at balloon pressure
  4. filtrationUpon completion, the catalyst was filtered
  5. washwashing with additional ethanol
  6. concentrationThe filtrate was concentrated in vacuo
  7. custompurified by preparative HPLC (Polaris C18-A 10 μ 250×21.2 mm column, 30% to 95% acetonitrile-0.1% trifluoroacetic acid in water)

出典と根拠

ORDレコード
ord-ff1b152de3d6417691fccfeb844639d0
出典データセット
uspto-grants-2008_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07320972B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート